OBJECTIVES:  The goal was to analyse changes in the nominal and real value of the social insurance and patient costs of reimbursed medical aids. (In Hungary, medical aids are medical devices and products used independently by patients, eg. hearing aids, wheelchairs, bandages.) METHODS:  A time series dataset was created based on the publicly available annual data of the National Health Insurance Fund on the reimbursed sales of medical aids in Hungary between 2005-2015. Based on the created time series, an analysis was carried out comparing 2015 data to that of years 2005 and onwards. Reimbursement and patient contribution costs were analysed in aggregates and in a breakdown by main ISO groups. The changes in costs were compared to consumer price indices (CPI) published by the Hungarian Central Statistical Office. RESULTS: Between 2005-2015, reimbursement expenditures increased by 40.0% and patient contribution costs by 46.7%. Based on the CPIs, this equals a 3.4% and a 1.2% real value increase, respectively. The largest annual rise in the real value of the analysed costs was between 2013-2015. For this period, the total of these costs increased from 60.7 million HUF to 69.8 million HUF. Reimbursement and patient contribution costs increased in real value by 14.5% and 19.5%, respectively. The most substantial growth rates are from ISO groups 02 (bandages), 06 (ortheses and prostheses) and 21 (hearing aids, electrolarynges and optical aids), for both reimbursements and patient contributions. CONCLUSIONS:  Based on the analysis, social insurance and patient contribution costs of medical aids have increased considerably in real value between 2013-2015. For both health insurance and patient contribution costs, further research is necessary to determine the extent to which possible changes in sales volume and prices induced the growth of costs, and whether the quality of patient medical aid provision increased simultaneously.